MedDataX Logo

Comparing Pain and Bruising of Subcutaneous Heparin Injection

NCT ID: NCT01645774

Last Updated: 2012-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subcutaneous heparin injection is one of the most frequent nurses' clinical care. This study aimed to Identify and compare the effects of four different injection duration on pain and bruising associated with subcutaneous injection of heparin in 90 patients. Four injection methods were used for them:

A: 10s injections duration

B: 10s injection duration and waiting 10s before withdrawing the needle

C: 15s injection duration and waiting 5s before withdrawing the needle

D: 5s injection duration and waiting 15s before withdrawing the needle.

Bruising was measured by a flexible millimeter ruler 48h after each injection; and pain was measured by pain visual analogue scale immediately after the injection. Data will be analyzed by SPSS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Bruising

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

subcutaneous injection heparin injection duration bruising pain decrease pain decrease bruising

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

10s injections duration

10s injections duration

Group Type EXPERIMENTAL

10s injections duration

Intervention Type PROCEDURE

10s injections duration

10s injection duration , waiting 10s

10s injection duration and waiting 10s before withdrawing the needle

Group Type EXPERIMENTAL

10s injection duration and waiting 10s before withdrawing the needle

Intervention Type PROCEDURE

10s injection duration and waiting 10s before withdrawing the needle

15s injection duration,waiting 5s

15s injection duration and waiting 5s before withdrawing the needle

Group Type EXPERIMENTAL

15s injection duration and waiting 5s before withdrawing the needle

Intervention Type PROCEDURE

15s injection duration and waiting 5s before withdrawing the needle

5s injection duration , waiting 15s

5s injection duration and waiting 15s before withdrawing the needle

Group Type EXPERIMENTAL

5s injection duration and waiting 15s before withdrawing the needle

Intervention Type PROCEDURE

5s injection duration and waiting 15s before withdrawing the needle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

10s injections duration

10s injections duration

Intervention Type PROCEDURE

10s injection duration and waiting 10s before withdrawing the needle

10s injection duration and waiting 10s before withdrawing the needle

Intervention Type PROCEDURE

15s injection duration and waiting 5s before withdrawing the needle

15s injection duration and waiting 5s before withdrawing the needle

Intervention Type PROCEDURE

5s injection duration and waiting 15s before withdrawing the needle

5s injection duration and waiting 15s before withdrawing the needle

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inclination to participate in the study; filling out the form of conscious satisfaction
* Ability to answer the questions and determining the rate of pain
* Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection.

Exclusion Criteria

* Death,
* Discharge
Minimum Eligible Age

53 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mashhad University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tayebe Pourghaznein

faculty member,MSc of Nursing

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

interventional

Identifier Type: -

Identifier Source: org_study_id